Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " November 21, 2012":" December 21, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" November 21, 2012":" December 21, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (32 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed An Evaluation of a Rapid Test for HIV
Condition: HIV Seropositivity
Intervention: Device: Rapid testing for HIV
2 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
3 Completed Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care
Condition: HIV Positive Youth That Are Newly Engaged in Care
Interventions: Behavioral: Project ACCEPT;   Behavioral: HEALTH
4 Withdrawn The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies
Condition: HIV Infections
Interventions: Behavioral: HIV Test Offer;   Behavioral: General Health Screen Offer
5 Completed Alcohol Harm Reduction Intervention Among Female Sex Workers in Mombasa, Kenya
Condition: Alcohol Use and STI/HIV Infections, Domestic Violence
Intervention: Behavioral: Behavioral Intervention for Alcohol Use
6 Completed Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART
Condition: HIV Infection
Interventions: Dietary Supplement: Vitamin D3 50,000 IU;   Dietary Supplement: Vitamin D3 placebo
7 Active, not recruiting Behavioral Intervention to Enhance HIV Test/Treat
Condition: HIV/AIDS
Interventions: Behavioral: Infectiousness Risk Reduction;   Behavioral: General Health Improvement
8 Recruiting Evaluating the Safety, Tolerance, and Pharmacokinetics of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in Children Infected With HIV and TB
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir
9 Unknown  Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum
Conditions: Malaria in Pregnancy;   HIV Infection
Interventions: Drug: cotrimoxazole daily prophylaxis;   Drug: sulphadoxine-pyrimethamine
10 Completed Randomized Control Trial of Shang Ring Versus Forceps-guided Adult Male Circumcision in Southwestern Uganda.
Condition: HIV
Interventions: Procedure: Shang Ring Guided Circumcision;   Procedure: Forceps Guided Circumcision
11 Completed Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence
Conditions: Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS);   Self-Directed Violence
Intervention:
12 Active, not recruiting Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care
Condition: HIV
Interventions: Behavioral: FAmily-CEntered Advance Care Planning;   Behavioral: Healthy Living Control
13 Completed A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence
Condition: Acquired Immune Deficiency Syndrome
Intervention: Drug: No intervention
14 Completed A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista
Condition: Acquired Immune Deficiency Syndrome
Intervention: Drug: No intervention
15 Unknown  A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.
Condition: HIV
Intervention: Drug: Darunavir, Ritonavir and Rilpivirine
16 Completed A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 30 mg oral;   Drug: Midazolam 3 mg oral + GSK1265744 30mg oral;   Drug: GSK1265744 400 mg (200 nm);   Drug: GSK1265744 400 mg (1 micro m);   Drug: GSK1265744 400 mg (5 micro m)
17 Unknown  Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDS
Condition: Veterans With HIV/AIDS Diagnosis.
Intervention:
18 Recruiting Does Rosuvastatin Delay Progression of Atherosclerosis in HIV
Conditions: HIV;   Cardiovascular Disease
Interventions: Drug: Rosuvastatin;   Other: Placebo
19 Withdrawn A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid
20 Completed A Muli-Center, Open-Label, Randomized, Two-Period, Crossover Non-Inferiority Trial
Condition: Human Immunodeficiency Virus
Intervention: Device: Female condom

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.